Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Indrayani Biotech's 3-Year RORE % for the quarter that ended in Dec. 2025 was -446.33%.
The industry rank for Indrayani Biotech's 3-Year RORE % or its related term are showing as below:
BOM:526445's 3-Year RORE % is ranked worse than 97.95% of 975
companies
in the Business Services industry
Industry Median: 7.89
vs BOM:526445: -446.33
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Indrayani Biotech 3-Year RORE % Related Terms
Indrayani Biotech 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Indrayani Biotech's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:526445 vs CTAS, CPRT, GPN: 3-Year RORE % Comparison
For the Specialty Business Services subindustry, Indrayani Biotech's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indrayani Biotech 3-Year RORE % vs Business Services Industry
For the Business Services industry and Industrials sector, Indrayani Biotech's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Indrayani Biotech's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 3-year before.
Indrayani Biotech (BOM:526445) has a 3-Year RORE % of -446.33 as of Dec. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Indrayani Biotech and its competitors. According to the industry distribution chart, Indrayani Biotech ranks #955 out of 975 companies in the Business Services industry, placing it in the top 97.9%.
Is Indrayani Biotech's 3-Year RORE % too high?
Indrayani Biotech's current 3-Year RORE % is -446.33. Based on the distribution chart, Indrayani Biotech ranks #955 out of 975 companies in the Business Services industry, which is in the bottom quartile relative to peers. Overall, Indrayani Biotech has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indrayani Biotech's 3-Year RORE % compare to CTAS and CPRT?
According to the Business Services industry distribution chart, Indrayani Biotech ranks #955 out of 975 companies for 3-Year RORE %. This places Indrayani Biotech in the lower half of its industry. The industry median 3-Year RORE % is 7.89. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Business Services company?
The median 3-Year RORE % among Business Services companies is 7.89, based on 975 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Indrayani Biotech and its competitors. For the Business Services industry, the median 3-Year RORE % is 7.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indrayani Biotech's current 3-Year RORE % is -446.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indrayani Biotech stock overvalued right now?
Based on GuruFocus' analysis, Indrayani Biotech (BOM:526445) is currently considered Possible Value Trap. The stock's GF Value™ is ₹41.56, compared to a current price of ₹7.89 — trading 81% below its estimated fair value. The current 3-Year RORE % is -446.33. Indrayani Biotech's overall GF Score™ is 52/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Indrayani Biotech (BOM:526445), the current 3-Year RORE % is -446.33 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indrayani Biotech (BOM:526445) Overvalued in 2026?
Based on GuruFocus' analysis, Indrayani Biotech stock appears to be undervalued.
The current stock price of ₹7.89 is trading 81% below its estimated GF Value™ of ₹41.56.
GuruFocus considers Indrayani Biotech to be Possible Value Trap.
Key valuation signals for BOM:526445:
3-Year RORE %: -446.33
GF Value™: ₹41.56 vs. price of ₹7.89 (81% below fair value)
No single metric tells the full story. See the BOM:526445 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indrayani Biotech Ltd operates in the Tri-segment i.e. Foods & Hospitality, Engineering and Healthcare divisions. The company generates its revenue from the sale of food, beverages, and other items; the Sale of Engineering products & Others. The majority of its revenue is generated from the sale of food, beverages, and other items.
52GF Score
Get the complete analysis for BOM:526445
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:526445 has been successfully added to your 
